We make the invisible visible
Proteins are the building blocks of viruses, cells, and enzymes. Fully understanding them requires access to imaging their often very rapid motion. An international team of researchers have recently published a study showing that the ultrashort X-ray pulses of the FemtoMAX beamline are enough for making images of, in this case, stationery, protein crystals with
In the sphere of human antibody therapeutics, the DutaFab platform shows broadening potential. Pharmaceutical giant Roche has developed ‘dual targeting’ Fab molecules containing two spatially independent binding sites for targeting distinct antigens. Their recent study, published in Nature Communications, demonstrates the high efficacy of these bispecific monoclonal antibodies for VEGFA and PDGF-BB growth factors related
A group of researchers from Sweden and Germany provides proof of concept for implementing serial crystallography at MAX IV in a recent study. The researchers have studied three different proteins using high-viscosity extrusion and fixed-target methods. The acquired data is promising and shows a clear path towards confidently starting serial crystallography experiments at the BioMAX
An international team of researchers has investigated the industrially important atomic layer deposition procedure for deposition of hafnium oxide on indium arsenide. Using ambient pressure X-ray photoelectron spectroscopy, the researchers could follow the oxide formation under industry-relevant conditions. The results of the research play a significant role in the future development of low-power and